Clinical Trial Update: A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Zemplar and Hectorol on intestinal calcium absorption in patients with end-stage renal disease and secondary hyperparathyroidism; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism

Drugs mentioned

• Hectorol (doxercalciferol)
• Zemplar (Paricalcitol)

Snippet

Sponsor: Abbott | Conditions: Chronic Kidney Disease, Stage 5, Secondary Hyperparathyroidism | Phase 4 | Status: COMPLETED | Results posted: 2009-05-20